You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
|
---|---|
Published in |
JAMA: Journal of the American Medical Association, April 2024
|
DOI | 10.1001/jama.2024.2396 |
Pubmed ID | |
Authors |
Ian T. T. Liu, Aaron S. Kesselheim, Edward R. Scheffer Cliff |
X Demographics
The data shown below were collected from the profiles of 535 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 127 | 24% |
Spain | 27 | 5% |
United Kingdom | 22 | 4% |
India | 19 | 4% |
France | 15 | 3% |
Canada | 14 | 3% |
Italy | 12 | 2% |
Colombia | 10 | 2% |
Australia | 10 | 2% |
Other | 89 | 17% |
Unknown | 190 | 36% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 326 | 61% |
Scientists | 107 | 20% |
Practitioners (doctors, other healthcare professionals) | 88 | 16% |
Science communicators (journalists, bloggers, editors) | 14 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 4 | 44% |
Researcher | 2 | 22% |
Student > Ph. D. Student | 1 | 11% |
Unknown | 2 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 33% |
Biochemistry, Genetics and Molecular Biology | 2 | 22% |
Chemistry | 1 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 11% |
Unknown | 2 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1559. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#7,472
of 25,830,005 outputs
Outputs from JAMA: Journal of the American Medical Association
#217
of 36,862 outputs
Outputs of similar age
#90
of 242,451 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#2
of 443 outputs
Altmetric has tracked 25,830,005 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,862 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,451 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.